Microchimerism, the presence of a small number of cells that are genetically distinct from those of the host individual, has been linked to autoimmune diseases (1 ) , but it has also been a basis for the quest for cellbased noninvasive prenatal diagnosis. Although methods used for enriching rare cells remove the bulk of the background cells, processed samples remain a mixture of target cells and a large majority of nontarget cells (2) (3) (4) (5) (6) (7) .
The analytical definition of rare cells solely on the basis of a biochemical parameter entails the risk of contaminating the target cell population (8 ) . This problem even applies to an excellent marker, such as the embryonic hemoglobin produced by nucleated red blood cells, a subpopulation of fetal microchimeric cells present in the blood of pregnant women (9 ) . Fluorescence in situ hybridization, a powerful tool for diagnosis, is also not a reliable tool in the search of rare cells because it may yield false-positive signals (2 ) . Furthermore, Y chromosome-specific fluorescence in situ hybridization obviously does not detect female fetal cells. Nevertheless, individual identification of the genomic origin of particular target cells is imperative for cell-based noninvasive prenatal diagnosis. Such unambiguous identification is feasible via DNA fingerprint analysis of single cells, as has been shown with candidate target cells preenriched and defined on the basis of biochemical markers (10 ) . Identification of the genomic origin of single cells by DNA fingerprint analysis is independent of sex and cell type; however, the exhaustion of the available DNA for target cell identification impedes further analysis of the cells. There is clearly a need for a method that allows both genomic identification and molecular genetic and cytogenetic analysis of the same cell.
We present a whole-genome amplification (WGA) 4 method that allows multiple molecular genetic and cytogenetic analysis of single cells while covering a wide range of resolution. For this purpose, we have adapted our previously reported method of lowvolume on-chip DNA fingerprint analysis (10 ) to isothermal WGA (iWGA). As a proof of principle, we used preparations of peripheral blood mononuclear cells spiked with cells from a carcinoma cell line to mimic both a microchimeric sample (e.g., fetal cells present in the blood of pregnant women) and a sample containing a few cells with chromosomal imbalances on a background of chromosomally balanced cells (e.g., circulating tumor cells). After defining candidate target cells on the basis of a biochemical marker, semiautomated detection, and isolation, we performed lowvolume on-chip iWGA. We assessed the suitability of the iWGA products for DNA fingerprint analysis (a post hoc genomic identification of the candidate cells that yields a postidentification pool of verified amplicons), as well as for sequencing and metaphase comparative genomic hybridization (mCGH) (Fig. 1 ).
Materials and Methods

CELLULAR METHODOLOGY
Detailed information regarding cell preparations, staining, and virtual enrichment of candidate target cells is provided in the Text 1 file in the Data Supplement that accompanies the online version of this article at http://www.clinchem.org/content/vol57/issue7. In brief, the candidate microchimeric cell population in Cytospin preparations was defined by immunofluorescence staining for cytokeratin (11 ) . Combination with the nuclear dye TO-PRO-3 was chosen for the rare cell-detection software (Metafer P module RCDetect; Metasystems) to identify the HT-29 cells on the basis of a preestablished set of parameters, as described previously (10 ).
LASER MICRODISSECTION
As described in the Text 1 file in the online Data Supplement, the position information of the candidate cells was fed into the software for laser microdissection and pressure catapulting (PALM; Zeiss MicroImaging). The catapulted cells were collected at the reaction sites of chemically modified chips (AmpliGrid AG240F; LTF Labortechnik).
iWGA OF CANDIDATE CELLS
Reaction sites containing microdissected samples were charged with 0.75 L of a cell-lysis mix (AmpliGrid Cell Extraction Kit; LTF Labortechnik) and overlaid with 5 L of PCR oil (Sealing Solution; LTF Labortechnik) as recommended by the manufacturer. After celllysis treatment at 75°C and enzyme inactivation at 95°C for 5 min and 2 min, respectively, iWGA of the lysed samples was performed with the illustra GenomiPhi V2 DNA Amplification Kit (GE Healthcare). For this purpose, we added 0.5 L of sample buffer (illustra GenomiPhi V2 DNA Amplification Kit) containing 1ϫ AdvaBlue PCR dye (LTF Labortechnik) to lysed samples and denatured the sample at 95°C for 3 min. We added another 0.5 L containing a mixture of reaction buffer and enzyme mix (10:1; illustra GenomiPhi V2 DNA Amplification Kit) and performed iWGA at 30°C for 3 h. The enzyme was then inactivated at 65°C for 10 min. All thermal-incubation steps were carried out on a slide cycler (AmpliSpeed ASC400D; Advalytix). iWGA products (approximately 1.5 L) were collected from reaction sites, diluted with 8 L of water, and stored at 4°C until further use. We used 1-L aliquots of diluted iWGA products to perform DNA fingerprint analysis and single-nucleotide polymorphism (SNP) sequencing.
DNA FINGERPRINTING
We used the PowerPlex 16 System (Promega) for this analysis. iWGA aliquots were placed on AmpliGrid reaction sites and allowed to air-dry. The respective sites were charged with 1 L of a multiplex PCR master mix, consisting of 0.032 L Ampli-Taq Gold DNA Polymerase (Applied Biosystems), 0.1 L Gold Star 10ϫ Buffer, 0.1 L Powerplex 16 10ϫ Primer Pair Mix, and 0.768 L nuclease free water (all from Promega), and covered with 5 L of Sealing Solution. Amplification was performed on the AmpliSpeed ASC400D via the PCR, as recommended by the manufacturer. The PCR products were then collected from the reactive sites and forwarded for PCR cleanup (Wizard SV Gel & PCR Clean-Up System; Promega) according to the manufacturer's recommendations. DNA profiles were compiled from electropherograms (3730 DNA Analyzer; Applied Biosystems) with GeneMapper 4.0 software and analyzed as previously described (10 ) . We defined PCR performance by the quotient of the number of detected products and the theoretical maximum of possible PCR products, calculated from heterozygous loci only. Allele dropout (ADO) was defined as the ratio of the number of heterozygous loci yielding single peaks to the total number of heterozygous loci. Amplification failure was calcu- PCR performance (%) ϭ n peak n max. peak ⅐ 100, (1) ADO (%) ϭ n locus, single peak n heterozygous locus ⅐ 100, and
Amplification failure (%) ϭ n locus, no peak n max. loci ⅐ 100,
where n peak is number of peaks detected at heterozygous loci only, n max. peaks is the maximum number of peaks at heterozygous loci only, n locus, single peak is the number of heterozygous loci yielding only a single peak, n heterozygous locus is the total number of heterozygous loci, n locus, no peaks is the number of loci lacking peaks, and n max. loci is the total number of analyzed loci.
SNP SEQUENCING
Sequencing data were retrieved from reactions that used iWGA products fed directly into the PCR for SNP detection. We analyzed the following SNPs known to be heterozygous in HT-29 cells: BRAF 5 (v-raf murine sarcoma viral oncogene homolog B1) c.1799 TϾA; APC (adenomatous polyposis coli) c.2557 TϾG; and PIK3CA (phosphoinositide-3-kinase, catalytic, ␣ polypeptide) c.1345 CϾA. In brief, SNP loci were amplified with 0.5 L of iWGA products and 0.5 L of the respective primers [APC (forward/reverse), 5Ј-CAC GACGTTGTAAAACGAAGGAAGCATTATGGGACAT GG-3Ј/5Ј-TTCCATGACTTTGGCAATCTG-3Ј; BRAF (forward/reverse), 5Ј-TCATCCTAACACATTTCAAG CC-3Ј/5Ј-CACGACGTTGTAAAACGACTTTGTGAAT ACTGGGAACTATGAAA-3Ј; PIK3CA (forward/reverse), 5Ј-CACGACGTTGTAAAACGACAAGTGCCT TTTCCAATCAATC-3Ј/5Ј-TTCATCATAAATTCCTGAA GCTC-3Ј], 6 L HotStar Taq Master Mix Kit (Qiagen), and 5 L PCR-grade water. After an initial denaturation step at 95°C for 15 min, the PCR was cycled 35 times at 95°C, 57°C, and 72°C for 45 s each before a final extension step at 72°C for 5 min and cooling to 8°C. For the sequencing reaction, we added 0.5 L of the SNP PCR products to 1 L sequencing buffer (ABI BigDye Terminator v3.1 Cycle Sequencing Kit; Applied Biosystems), 0.5 L primer M13, and 7.0 L PCRgrade water. The sequencing reaction was performed with 25 cycles of denaturation at 95°C for 30 s, annealing at 50°C for 15 s, and extension at 60°C for 4 min; samples were then cooled to 8°C. The sequencing products were then purified by vacuum filtration (Millipore cleanup plates) and forwarded to analysis on an ABI Prism 3130xl Genetic Analyzer using SeqScape analysis software (Applied Biosystems).
CYTOGENETIC ANALYSIS
For mCGH (12 ), we reamplified and purified the initial iWGA products. We transferred 1 L of the iWGA product for an in-tube ⌽29 reamplification with the illustra GenomiPhi V2 DNA Amplification Kit (GE Healthcare) and subsequently purified the reamplified samples with the QIAamp DNA Micro Kit (Qiagen), according to the manufacturers' protocols. The purified samples were recovered from the spin columns with 30 L of water. Before labeling, we assessed the DNA yield with a NanoDrop Spectrophotometer (Thermo Fisher Scientific) and forwarded the required amount of DNA for restriction enzyme digestion with AluI and RsaI (Promega) at 37°C for 2 h. We then used the BioPrime DNA Labeling System (Invitrogen) to label 300 ng of the amplified sample DNA (single cells) and "low cell" reference DNA (obtained from 10 cells of normal cultured lymphocytes). Random primers (octamers) were annealed to the denatured DNA template and extended with Klenow fragment in the presence of biotin-16-dUTP (Roche Diagnostics) for sample DNA and digoxigenin-11-dUTP (Roche Diagnostics) for reference DNA. Samples were concentrated with Microcon YM-30 spin columns (Millipore). In a single tube, 45 L biotin-labeled sample and 45 L digoxigenin-labeled reference DNA were added to 80 L human Cot-1 DNA (Roche Diagnostics), 5 L salmon testes DNA (Sigma-Aldrich), 17.5 L 3 mol/L sodium acetate (pH 5.2; Sigma-Aldrich), and 481 L of cold absolute ethanol. After gentle mixing, the samples were precipitated overnight at Ϫ20°C.
For CGH analysis, metaphase spreads were prepared according to standard procedures from stimulated peripheral blood lymphocytes obtained from a healthy male proband (46,XY). Chromosomal metaphase preparations were incubated with RNase A [Roche Diagnostics; 100 g/mL in 2ϫ standard saline citrate (SSC) (0.30 mol/L NaCl and 0.030 mol/L sodium citrate)] in a moist chamber at 42°C for 30 min, rinsed 3 times with 2ϫ SSC, and digested with 30 mg/L pepsin (Sigma-Aldrich; diluted in 0.01 mol/L HCl) at 37°C for 1 min, 45 s. The slides were rinsed 3 times with 1ϫ PBS (8 g/L NaCl, 0.2 g/L KCl, 0.2 g/L KH 2 PO 4 , 1.37 g/L Na 2 HPO 4 ⅐ 2H 2 O); dehydrated in an ascending ethanol series; denatured in 700 mL/L formamide containing 2ϫ SSC (pH 7.15) at 73°C for 1 min, 50 s; dehydrated in an ascending series of ice-cold ethanol; and dried at 42°C on a heating plate. The precipitated mixture of sample and reference DNA was washed with 700 mL/L ethanol, dried at 42°C, and incubated with formamide and 300 g/L dextran sulfate at 42°C while shaking at 600 rpm on an incubator (Thermomixer compact; Eppendorf) for 30 min. For denaturation, the DNA mixture was incubated at 78°C for 7 min, preannealed at 42°C for 30 min, and then placed on slides containing the denatured chromosomes. Hybridization was performed at 37°C for 48 h in a water bath.
After hybridization, the slides were washed 3 times with 4ϫ SSC (0.60 mol/L NaCl and 0.060 mol/L sodium citrate) containing 2 mL/L Tween 20 at 42°C, washed 3 times with 1ϫ SSC (0.15 mol/L NaCl and 0.015 mol/L sodium citrate) at 60°C, and blocked with 30 g/L BSA (in 4ϫ SSC containing 2 mL/L Tween 20). For detection of biotin and digoxigenin, the samples were incubated with Cy3.5-labeled avidin (5 ng/L) and fluorescein isothiocyanate-labeled antidigoxigenin (2 ng/L) antibodies diluted in 10 g/L BSA for 50 min. The slides were washed 3 times in 4ϫ SSC containing 2 mL/L Tween 20, counterstained with 4Ј,6-diamidino-2-phenylindole dihydrochloride (SigmaAldrich) to allow for chromosome identification, and mounted in phenylenediamine mounting medium. For image capture and processing of CGH data, we used a Leica DMRXA microscope (Leica) equipped with Leica Q-FISH and Leica Q-CGH. The diagnostic thresholds used to score losses and gains were 0.8 and 1.2.
For comparison purposes, we isolated genomic DNA from bulk cultured HT-29 cells and performed mCGH according to standard protocols.
Results
VIRTUAL PREENRICHMENT OF CANDIDATE TARGET CELLS
Cells positive for both cytokeratin and TO-PRO-3 were found on all slides (see Fig. 1 in the online Data Supplement). Selected cells were chosen from the image gallery of the rare cell-detection software and forwarded to laser microdissection and pressure catapulting onto AmpliGrid slides.
DNA FINGERPRINT ANALYSIS OF iWGA SAMPLES
DNA fingerprinting of iWGA aliquots was performed with nonstained HT-29 cells at the level of 10 pooled cells and 5 pooled cells (see Table 1 in the online Data Supplement). The respective samples yielded PCR products at all loci. The PCR performance was 97% (range, 96%-100%) and 94% (range, 92%-96%) for the template levels of 10 cells and 5 cells, respectively. ADO occurred in 5% (range, 0%-8%) at the 10-cell level and in 13% (range, 8%-15%) at the 5-cell level (Table 1; see Table 2 in the online Data Supplement). We did not detect allele dropin or erroneous amplification (see Table 1 in the online Data Supplement).
We compiled the PCR profiles ( Fig. 2 ; see Fig. 2 in the online Data Supplement for the full profile) for 7 single cells double-positive for anticytokeratin and TO-PRO-3 staining (see Table 1 and Fig. 1 in the online Data Supplement). The DNA fingerprint analysis of the respective iWGA aliquots yielded a mean PCR performance of 87.4% (range, 58%-100%). Amplification failure and ADO were observed in 2.7% (range, 0%-13%) and 19% (range, 0%-54%), respectively (Table 1;  see Table 2 in the online Data Supplement). Erroneous PCR and allele dropin were not detected (see Table 1 in the online Data Supplement).
The generated DNA profiles showed unambiguous data from samples at all template levels (see Table 1 in the online Data Supplement). Loci were informative in 44 of 48 instances at the 10-cell level, in 41 of 48 cases at the 5-cell level, and in 99 of 109 instances at the single-cell level. Summarizing the allelic pattern across each sample yielded an allocation rate of 100%.
SEQUENCING OF iWGA SAMPLES
Sequencing of 3 SNPs known to be heterozygous in HT-29 cells produced successful PCR results for all tested SNP loci at the 10-and 5-cell levels (9 of 9 reactions each) and for 16 of 18 reactions at the single-cell level (Table 2;  see Table 3 in the online Data Supplement). The heterozy- gous signals were assessed quantitatively, and the signal ratios ranged from subheterozygous (wild type-mutant ratio, 1:4) to superheterozygous (wild type-mutant ratio, 5:1) owing to preferential amplification in the course of iWGA. The ADO rates were similar across the reactions at all levels [ranging between 56% (5 of 9 loci) and 67% (6 of 9 and 12 of 16 loci, respectively], yielding PCR performances of 72% (10-cell level), 67% (5-cell level), and 63% (single-cell level) (see Table 3 in the online Data Supplement). In 2 additional approaches, we pooled the iWGA products of 5 single cells and the products of 3 single cells (Table 2; see Table 3 in the online Data Supplement) after DNA fingerprint analysis revealed the cells (APC and BRAF) . The PIK3CA locus could not be evaluated because of high background levels.
CHROMOSOMAL CGH FROM iWGA SAMPLES
To check the concordance between the CGH profiles, we compared chromosomal CGH data of iWGA aliquots from 3 single cells double-positive for cytokeratin and TO-PRO-3 with non-preamplified DNA isolated from cultured HT-29 cells (bulk HT-29 genomic DNA) ( Fig. 3 ; see 
Discussion
The objective of this work was to create a process for linking unambiguous identification of single cells to subsequent analyses covering a wide range of resolutions. This process expands on a recently described method that permits automated target cell detection and virtual enrichment, microdissection, and identification of the genomic origin of haploidentical single cells by means of DNA fingerprinting (10 ). Our implementation of an iWGA step between the laser microdissection of cells and DNA fingerprinting created the potential to perform multiple analyses from a particular cell. The aliquots of the iWGA products permitted both sex-and cell type-independent identification of the cell's genomic origin and the analysis of specific genetic features.
One purpose of DNA fingerprint analysis of iWGA products was to assess the quality of the DNA amplified from single cells. Furthermore, we wanted to know whether the quality of the respective DNA profiles would still be acceptable for verifying the genomic origin of a particular isolated candidate target cell. Such results are a prerequisite for generating pools of amplification products for further molecular genetic and cytogenetic analysis. We found DNA fingerprinting to be compatible with the incorporation of a preceding iWGA step. PCR performance was high and unaffected by potential disturbances due to fixation or labeling. The data rule out contamination because the allelic patterns are unambiguous. The fact that DNA fingerprinting was successful not only demonstrated its feasibility in combination with iWGA but also documented the respective loci to be correctly amplified. Thus, DNA fingerprint analysis provides a benefit in 2 ways: It allows unambiguous allocation of cells from microchimeric samples to one of 2 possible genotypes, and it may be used as a quality control. The amplification of degraded DNA would produce partial DNA profiles. The advantage of detecting and eliminating degraded samples at this stage of the process is welcome.
Only amplification methods that do not implicate DNA fragmentation may yield full DNA profiles. WGA methods that use restriction enzymes may cause amplification failure in the markers of the DNA fingerprinting assay. Random fragmentation is even less applicable because this approach lacks any possibility to predict the sites of fragmentation. The iWGA method we used leads to comparatively less-effective amplification. Therefore, we carried out a double round of iWGA, which might contribute, however, to some decrease in the signal-to-noise ratio in mCGH.
The detection of heterozygous SNPs was comparatively less effective. Although a complete (heterozygous) SNP profile of HT-29 cells could be obtained by summarizing the data from 2 to 4 single cells, sequencing of pooled iWGA samples did not produce a full SNP "profile." The reason for this effect is not clear. The fact that both molecular genetic methods rely on intact DNA makes DNA degradation unlikely to be the main cause of this effect. As discussed by Rohlin et al. (13 ) , the lowest abundance of mutant alleles that can be detected by Sanger sequencing varies between 15% and 50%. In addition, we cannot rule out that differences in the chromosomal locations of the respective loci (short tandem repeats and SNPs) or in the performance of the iWGA might have influenced the PCR performance.
The CGH data correspond well with published profiles for the HT-29 cell line, despite some additional gains and losses seen in single-cell CGH analyses. Using reference DNA from iWGA results for pooled microdissected cells, we obtained interpretable profiles for all (14 ) ; however, we did not detect the reported gain at chromosome 3q. The reported findings for chromosomes 5p, 7, 11, 17p, and 22 could be retrieved in our data obtained from single cells (gains at chromosomes 7 and 11) but not from bulk cells (gains only at 7q and 11q). At chromosome 13, one single cell lacked the published gain of DNA. None of our CGH data retrieved the gain of 18p, whereas all CGH profiles showed the loss of 18q. A gain on chromosome 17q was detected for one of the isolated single cells, a result that may reflect the heterogeneity of this cell line, because this gain has also been reported elsewhere (15 ) . That report includes a loss of 6q, which we found in the CGH profile for bulk cells but not for single cells. In addition and in contrast to the cited publications, we detected gains of 9p and 20p at the single-cell level but not in the CGH profile for the bulk cells.
Some aberrations may be attributed to inherent problems of iWGA with rare cells. Differences among the single-cell CGH profiles (chromosomes 1p, 5q, 9q, 12q, 13p, 17q, 19p, X) were sometimes due to data just beyond signal thresholds (cell line/single cell: 6q; single cell/single cell: 1p, 5p, 9q, Xq). In other cases, the chromosomal profile was sigmoid, thereby exceeding (12p, 13p) or missing (19q) the ratio limits. At other loci (5p, 7q), cell heterogeneity may be the reason for the averaging out of the gains and losses seen at the single-cell level but not at the level of the non-preamplified bulk cells. The results in other cases may be due to a heterogeneity seen only at the single-cell level, such as that reported by Kawai et al. (16 ) . Stochastic effects leading to unbalanced amplification are known to occur during amplification at low DNA template concentrations. Reducing the iWGA time would reduce these effects, thereby smoothing the profile; on the other hand, it would probably also lead to insufficient DNA quantities.
In combination with virtual preenrichment, we believe this approach to be promising for detecting chromosomal aberrations in cell-based noninvasive prenatal diagnosis. Furthermore, it may also be helpful in the analysis of circulating tumor cells, for which mCGH may be expected to be a useful tool for discriminating circulating tumor cells from nontumor cells, thereby permitting identification at the cytogenetic level. Further efforts will be taken to expand the applicability of this method toward its use in array CGH analysis. Thus far, our attempts to align the respective procedures have not been successful.
We have demonstrated the preselection of candidate target cells and single-cell iWGA to be compatible with multiple downstream molecular genetic and cytogenetic analyses. The identification of the genomic affiliation of cells from microchimeric samples can be performed unambiguously. Sequencing of iWGA aliquots at sites of heterozygous SNPs proved to be applicable, yet such sequencing is not free from ADO. The detection of chromosomal imbalances for the purpose of cell-based noninvasive prenatal diagnosis promises to be feasible, because new methods for efficient enrichment of fetal cells have been reported (5 ) . With these considerations taken together, we have followed a holistic approach that enables manifold molecular genetic and cytogenetic analyses of single and pooled identified cells, which we expect to be feasible for the analysis of microchimeric cells. This approach may also help in the analysis of other types of rare cells, such as circulating tumor cells, and in forensic medicine.
